[1]Lengyel,Miklós;Erdélyi,Ferenc;Pergel,Enikö;Bálint-Polonka,Ágnes;Dobolyi,Alice;Bozsaki,Péter;Dux,Mária;Király,Kornél;Hegedüs,Tamás;Czirják,Gábor;Mátyus,Péter;Enyedi,Péter[MolecularPharmacology,2019,vol.95,#6,p.652-660]
[2]Locationinpatent:experimentalpartMondal,Shyamal;Maity,Arindam;Naskar,Subhendu;Paira,Rupankar;Hazra,Abhijit;Sahu,KrishnenduB.;Saha,Pritam;Das,Saktipada;Banerjee,Sukdeb;Mondal,NirupB.[Synthesis,2011,#13,p.2079-2084]
[1]Banumathi;Jyothi,Mahima;Khamees,HussienAhmed;Khanum,ShaukathAra;Prabhakar,B.T.;Sherapura,Ankith;Zabiulla[JournalofMolecularStructure,2022,vol.1252]
[2]Zhang,Chunming;Leng,Ron;Hamilton,Chris;Sheng,Min;Tu,Siyu;Gu,Binghe;Bell,Bruce[OrganicProcessResearchandDevelopment,2019,vol.23,#10,p.2218-2224]
[3]Basavanna,V.;Bhadraiah,U.K.;Chandra;Chandramouli,M.;Doddamani,Shridevi;Kempaiah,C.;Lingegowda,N.S.;Ningaiah,S.[RussianJournalofGeneralChemistry,2021,vol.91,#11,p.2257-2266][Zh.Obshch.Khim.,2021,vol.91,#11,p.2257-2266]
Title: Miklós Lengyel, et al. Chemically Modified Derivatives of the Activator Compound Cloxyquin Exert Inhibitory Effect on TRESK (K 2P 18.1) Background Potassium Channel. Mol Pharmacol. 2019 Jun;95(6):652-660.